Drugs Made In America Acquisition Ownership | Who Owns Drugs Made In America Acquisition?
Drugs Made In America Acquisition Ownership Summary
Drugs Made In America Acquisition is owned by 216620.31% institutional investors, 26.77% insiders. Quarry lp is the largest institutional shareholder, holding 0% of DMAA shares.
DMAA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Drugs Made In America Acquisition | 216620.31% | 26.77% | -216547.08% |
Industry | Shell Companies Stocks | 6743.39% | 23.28% | -6666.67% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Quarry lp | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Quarry lp | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Quarry lp | - | - | -650.00K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Quarry lp | - | - | -650.00K |
Sold Out
Holder | Change |
---|---|
Quarry lp | -650.00K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 32 | 33.33% | 20,823,195 | 10.54% | 216,620 | 0.00% | 18 | -21.74% | 6 | - |
Mar 31, 2025 | 25 | - | 19,688,102 | - | 229,706 | - | 24 | - | - | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 18, 2025 | Drugs Made In America Acquisition LLC | - | Buy | - |
Feb 18, 2025 | Drugs Made In America Acquisition LLC | - | Buy | - |
Feb 18, 2025 | Stockwell Lynn | CEO and Exe. Chair of Board | Buy | - |
Feb 18, 2025 | Stockwell Lynn | CEO and Exe. Chair of Board | Buy | - |
Jan 29, 2025 | Drugs Made In America Acquisition LLC | - | Buy | - |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | 8 | 2 |
DMAA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools